In the fourth of a series of conversations at last week’s ViVE health-tech event, MM+M’s Marc Iskowitz sat down with KKR’s Christopher McFadden to discuss how private equity firms have upped their investments in health marketing agencies in recent years — a trend that has barely started yet — and to chart out a course for the next set of big-money deals.
Health-data 1:1: KKR’s Christopher McFadden on where PE is placing its bets in healthcare
At last week's ViVE health-tech event, MM+M’s Marc Iskowitz sat down with KKR's Christopher McFadden to discuss how private equity firms are investing in health marketing agencies.
